Common Stock, Shares, Outstanding of AGILE THERAPEUTICS INC from 31 Dec 2013 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
AGILE THERAPEUTICS INC quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2013 to 30 Jun 2024.
  • AGILE THERAPEUTICS INC Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2024 was 6,904,498, a 321% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 6,904,498 +5,263,693 +321% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 6,856,229 +5,924,128 +636% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 2,963,657 +2,104,255 +245% 31 Dec 2023 10-Q 12 Aug 2024 2024 Q2
Q3 2023 2,277,657 -36,749,166 -94% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 1,640,805 -10,719,352 -87% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 932,101 -2,433,321 -72% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 859,402 -2,175,499 -72% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 39,026,823 -55,702,562 -59% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 12,360,157 -80,568,048 -87% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 3,365,422 -84,898,319 -96% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 3,034,901 -84,528,852 -97% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 94,729,385 +7,294,781 +8.3% 30 Sep 2021 10-Q/A 30 Dec 2021 2021 Q3
Q2 2021 92,928,205 +5,630,600 +6.4% 30 Jun 2021 10-Q 26 Jul 2021 2021 Q2
Q1 2021 88,263,741 +1,050,529 +1.2% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 87,563,753 +17,753,448 +25% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 87,434,604 +28,132,478 +47% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 87,297,605 +42,665,276 +96% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 87,213,212 +43,597,955 +100% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 69,810,305 +35,432,976 +103% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 59,302,126 +24,924,797 +73% 30 Sep 2019 10-Q 28 Oct 2019 2019 Q3
Q2 2019 44,632,329 +10,255,000 +30% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 43,615,257 +9,366,989 +27% 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 34,377,329 +190,987 +0.56% 31 Dec 2018 10-K 20 Feb 2020 2019 FY
Q3 2018 34,377,329 +219,325 +0.64% 30 Sep 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 34,377,329 +5,570,931 +19% 30 Jun 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 34,248,268 +5,471,870 +19% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 34,186,342 +5,426,611 +19% 31 Dec 2017 10-K 12 Mar 2019 2018 FY
Q3 2017 34,158,004 +5,400,285 +19% 30 Sep 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 28,806,398 +53,679 +0.19% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 28,776,398 +38,348 +0.13% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 28,759,731 +6,444,119 +29% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 28,757,719 +6,465,552 +29% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 28,752,719 +6,514,582 +29% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 28,738,050 +6,577,817 +30% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 22,315,612 +3,680,740 +20% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 22,292,167 +3,699,199 +20% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 22,238,137 +3,645,169 +20% 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 22,160,233 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 18,634,872 +18,531,336 +17898% 31 Dec 2014 10-K 09 Mar 2016 2015 FY
Q3 2014 18,592,968 30 Sep 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 18,592,968 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q4 2013 103,536 31 Dec 2013 10-K 26 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.